NO912860D0 - 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridiner. - Google Patents

3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridiner.

Info

Publication number
NO912860D0
NO912860D0 NO1991912860A NO912860A NO912860D0 NO 912860 D0 NO912860 D0 NO 912860D0 NO 1991912860 A NO1991912860 A NO 1991912860A NO 912860 A NO912860 A NO 912860A NO 912860 D0 NO912860 D0 NO 912860D0
Authority
NO
Norway
Prior art keywords
alkyl
tetrahydropyridyl
alkoxy
formula
pyrrolopyridiner
Prior art date
Application number
NO1991912860A
Other languages
English (en)
Norwegian (no)
Other versions
NO912860L (no
Inventor
John Eugene Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO912860D0 publication Critical patent/NO912860D0/no
Publication of NO912860L publication Critical patent/NO912860L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO91912860A 1989-01-20 1991-07-22 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridiner. NO912860L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/000231 WO1990007926A1 (en) 1989-01-20 1989-01-20 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines

Publications (2)

Publication Number Publication Date
NO912860D0 true NO912860D0 (no) 1991-07-22
NO912860L NO912860L (no) 1991-07-22

Family

ID=22214793

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912860A NO912860L (no) 1989-01-20 1991-07-22 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridiner.

Country Status (26)

Country Link
US (2) US5051412A (zh)
EP (1) EP0379314B1 (zh)
JP (1) JPH0751576B2 (zh)
KR (1) KR920010642B1 (zh)
CN (1) CN1025998C (zh)
AT (1) ATE103282T1 (zh)
CA (1) CA2008016A1 (zh)
CS (1) CS277611B6 (zh)
DD (2) DD298398A5 (zh)
DE (1) DE69007501T2 (zh)
DK (1) DK0379314T3 (zh)
EG (1) EG18945A (zh)
ES (1) ES2062319T3 (zh)
FI (1) FI94641C (zh)
HU (1) HU206349B (zh)
IE (1) IE62757B1 (zh)
IL (1) IL93041A (zh)
MX (1) MX19185A (zh)
MY (1) MY106305A (zh)
NO (1) NO912860L (zh)
NZ (1) NZ232166A (zh)
PL (2) PL163626B1 (zh)
PT (1) PT92889A (zh)
WO (1) WO1990007926A1 (zh)
YU (1) YU47553B (zh)
ZA (1) ZA90393B (zh)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007926A1 (en) * 1989-01-20 1990-07-26 Pfizer Inc. 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines
US5451566A (en) * 1993-11-17 1995-09-19 Zeneca Limited Herbicidal pyrrolopyridine compounds
US6586458B1 (en) 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
ZA979961B (en) * 1996-11-15 1999-05-05 Lilly Co Eli 5-HT1F agonists
EP1082958A3 (en) * 1996-11-15 2002-12-11 Eli Lilly And Company 5-HT1F agonists in chronic pain
EP0875513A1 (en) * 1997-04-14 1998-11-04 Eli Lilly And Company Substituted heteroaromatic 5-HT 1F agonists
US5905084A (en) * 1997-11-14 1999-05-18 Eli Lilly And Company 5-HTIF -agonists effective in treating migraine
ZA989389B (en) * 1997-11-14 2000-04-14 Lilly Co Eli Pyrrolo [3,2-b] pyridine processes and intermediates.
US6476034B2 (en) 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US7332183B2 (en) 2002-12-26 2008-02-19 Pozen Inc. Multilayer dosage forms containing NSAIDs and triptans
NZ547327A (en) * 2003-11-21 2009-08-28 Array Biopharma Inc AKT protein kinase inhibitors
US7361764B2 (en) * 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
CA2573362A1 (en) 2004-07-27 2006-02-09 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
US7626021B2 (en) * 2004-07-27 2009-12-01 Sgx Pharmaceuticals, Inc. Fused ring heterocycle kinase modulators
EP2239262A3 (en) * 2004-07-27 2011-10-19 SGX Pharmaceuticals, Inc. Fused ring heterocycle kinase modulators
US20060100432A1 (en) 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7851476B2 (en) 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
NZ573979A (en) 2006-07-06 2012-02-24 Array Biopharma Inc Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
CA2656566C (en) 2006-07-06 2014-06-17 Array Biopharma Inc. Dihydrofuro pyrimidines as akt protein kinase inhibitors
WO2008006039A1 (en) 2006-07-06 2008-01-10 Array Biopharma Inc. Dihydrothieno pyrimidines as akt protein kinase inhibitors
ES2404668T3 (es) * 2006-12-29 2013-05-28 Rigel Pharmaceuticals, Inc. Triazoles sustituidos con arilo bicíclico puenteado y heteroarilo bicíclico puenteado, útiles como agentes inhibidores del axl
BRPI0813999A2 (pt) 2007-07-05 2019-10-01 Array Biopharma Inc ciclopentanos de pirimidil como inibidores de akt proteína cinase
MX2009014013A (es) * 2007-07-05 2010-01-28 Array Biopharma Inc Pirimidil ciclopentanos como inhibidores de la proteina cinasa akt.
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
NZ586720A (en) * 2008-01-09 2012-11-30 Array Biopharma Inc Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
EP2247578B1 (en) * 2008-01-09 2013-05-22 Array Biopharma, Inc. Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
CA2749843C (en) 2009-01-16 2017-09-05 Rigel Pharmaceuticals, Inc. Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
ES2604667T3 (es) 2009-06-17 2017-03-08 Vertex Pharmaceuticals Incorporated Inhibidores de la replicación de virus de influenza
CA2822057A1 (en) 2010-12-16 2012-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
SG194045A1 (en) 2011-04-01 2013-11-29 Genentech Inc Combinations of akt inhibitor compounds and abiraterone, and methods of use
KR20140022053A (ko) 2011-04-01 2014-02-21 제넨테크, 인크. Akt 및 mek 억제제 화합물의 조합물, 및 사용 방법
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
EP3068776B1 (en) 2013-11-13 2019-05-29 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
MX2016006200A (es) 2013-11-13 2016-08-08 Vertex Pharma Metodos para preparar inhibidores de la replicacion de virus de influenza.
WO2016062790A1 (en) * 2014-10-23 2016-04-28 Janssen Pharmaceutica Nv New pyrazolopyrimidine derivatives as nik inhibitors
JP6603713B2 (ja) 2014-10-23 2019-11-06 ヤンセン ファーマシューティカ エヌ．ベー． Ｎｉｋ阻害剤としての新規のチエノピリミジン誘導体
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
EP3294735B8 (en) 2015-05-13 2022-01-05 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272804A (en) * 1963-12-23 1966-09-13 Sterling Drug Inc Process and intermediates for preparing indoles
GB1141949A (en) * 1966-02-23 1969-02-05 Sterling Drug Inc 7-azaindole derivatives
IL48508A (en) * 1974-12-09 1979-10-31 Roussel Uclaf Pharmaceutical compositions comprising piperidylindole derivatives
FR2362628A1 (fr) * 1976-08-26 1978-03-24 Roussel Uclaf Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
FR2421899A1 (fr) * 1978-01-16 1979-11-02 Roussel Uclaf Nouveaux derives du tetrahydropyridinyl-indole et leurs sels, le procede de preparation et l'application a titre de medicaments de ces nouveaux produits
FR2444678A2 (fr) * 1978-12-22 1980-07-18 Roussel Uclaf Nouveau procede de preparation de derives du piperidyl-indole et de leurs sels
US5025096A (en) * 1985-08-22 1991-06-18 Mine Safety Appliances Company Preparation of indole and indole derivatives
WO1990007926A1 (en) * 1989-01-20 1990-07-26 Pfizer Inc. 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines

Also Published As

Publication number Publication date
ZA90393B (en) 1991-08-28
DD291559A5 (de) 1991-07-04
EG18945A (en) 1994-09-29
US5051412A (en) 1991-09-24
IE62757B1 (en) 1995-02-22
PL287840A1 (en) 1991-07-15
ATE103282T1 (de) 1994-04-15
CS277611B6 (en) 1993-03-17
EP0379314A1 (en) 1990-07-25
AU613259B2 (en) 1991-07-25
PT92889A (pt) 1990-07-31
CS26090A3 (en) 1992-02-19
IL93041A0 (en) 1990-11-05
JPH02247175A (ja) 1990-10-02
AU4867390A (en) 1990-07-26
KR920010642B1 (ko) 1992-12-12
CA2008016A1 (en) 1990-07-20
WO1990007926A1 (en) 1990-07-26
JPH0751576B2 (ja) 1995-06-05
YU47553B (sh) 1995-10-03
HUT57762A (en) 1991-12-30
DK0379314T3 (da) 1994-05-09
PL163626B1 (pl) 1994-04-29
FI913509A0 (fi) 1991-07-22
MX19185A (es) 1993-12-01
NO912860L (no) 1991-07-22
ES2062319T3 (es) 1994-12-16
IL93041A (en) 1994-02-27
FI94641C (fi) 1995-10-10
CN1044465A (zh) 1990-08-08
DD298398A5 (de) 1992-02-20
HU206349B (en) 1992-10-28
MY106305A (en) 1995-04-29
IE900210L (en) 1990-07-23
US5169947A (en) 1992-12-08
EP0379314B1 (en) 1994-03-23
YU9990A (en) 1992-05-28
DE69007501D1 (de) 1994-04-28
KR900011772A (ko) 1990-08-02
CN1025998C (zh) 1994-09-28
FI94641B (fi) 1995-06-30
DE69007501T2 (de) 1994-06-30
NZ232166A (en) 1992-10-28
PL283354A1 (en) 1991-08-12

Similar Documents

Publication Publication Date Title
DK0379314T3 (da) 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridiner
CS845583A2 (en) Zpusob pripravy 4 ep homoerythromycinu a
FI945703A0 (fi) 3,4,4-trisybstituoitujen piperidinyyli-N-alkyylikarboksylaattien ja välituotteiden valmistus
ES8605821A1 (es) Un procedimiento para la preparacion de aciltripeptidos in- munoestimulantes
AU2215588A (en) Substituted cycloalkanols
GR3024925T3 (en) Antifungal agent, its preparation and microorganism therefor
GR3036754T3 (en) Use of isoxazole- and crotonamide derivatives for the manufacture of a medicament for the treatment of cancers
DE59300623D1 (de) Führung für den Schaft eines Offenend-Spinnrotors.
KR880701707A (ko) 2,3-디아미노아크릴로니트릴 유도체
DK0438813T3 (da) Nyt antibiotikum, deoxymulundocandin, en fremgangsmåde til dets fremstilling samt dets anvendelse som lægemiddel
ZA200003035B (en) Compounds of 7-oxo-2,3,7,14-tetrahydro-1H-benzo[B]-pyrano[3,2-H] acridin carboxylate, a process for their preparation and pharmaceutical compositions containing them.
EP0116255A3 (en) Treatment of migraine with n-alkyl-piperidinyl benzoate derivatives
FI945750A (fi) 3-(fenyylialkyyliaminoalkyylioksi)-5-fenyylipyratsoli-yhdisteet sekä menetelmät ja välituotteet niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet
NL7705801A (en) Analgesic decahydro-isoquinolines - with 4A phenyl substits.
PT81324A (en) Process for the preparation of s-aralkyltrithiophosphonate having an insecticidal effect
EP0171812A3 (en) Cephem derivatives
CS153685A1 (en) Treatment method of staple yarn spinned by rotor system
HUP9903171A2 (hu) Duloxetin alkalmazása figyelemcsökkenéssel/hiperaktivitással kapcsolatos rendellenességek kezelésére alkalmas gyógyászati készítmények előállítására
ES8609254A1 (es) Un procedimiento para preparar un derivado de piridinodicar-boxilato
IT8722133A0 (it) Complesso di motorizzazione singola, ad intercambiabilita'facilitata, per l'azionamento individuale di fusi di macchine tessili a fusi.